Keep on dreaming. A positive vote was totally expected so the stock won't move much. How long have you been trading biotechs? You seem to be more of a dreamer than an investor. EXAS may grind higher from here but there is a long way to go from a positive FDA panel vote to actually getting final approval, shipping and marketing a product, etc. etc. Plus the overall environment for the Biotech sector is very negative recently. Investors are running from risk to more value stocks with existing profits and revenue instead of future potential revenue.